Compare GTLB & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTLB | SHC |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.2B |
| IPO Year | 2021 | 2020 |
| Metric | GTLB | SHC |
|---|---|---|
| Price | $52.04 | $17.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 10 |
| Target Price | ★ $55.71 | $22.72 |
| AVG Volume (30 Days) | ★ 3.6M | 1.7M |
| Earning Date | 09-01-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.28 |
| Revenue | $955,224,000.00 | ★ $1,163,617,000.00 |
| Revenue This Year | $18.54 | $7.16 |
| Revenue Next Year | $15.73 | $5.94 |
| P/E Ratio | ★ N/A | $65.05 |
| Revenue Growth | ★ 25.81 | 5.74 |
| 52 Week Low | $18.73 | $13.09 |
| 52 Week High | $55.55 | $19.85 |
| Indicator | GTLB | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 66.79 | 39.98 |
| Support Level | $45.11 | $16.74 |
| Resistance Level | $55.55 | $19.75 |
| Average True Range (ATR) | 1.81 | 0.48 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 85.15 | 0.57 |
GitLab Inc operates on an all-remote model. GitLab is a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation, following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, & the Asia Pacific. It focused on accelerating innovation & broadening the distribution of its platform to companies across the world.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.